BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 35163706)

  • 21. Inhibition of cathepsin X reduces the strength of microglial-mediated neuroinflammation.
    Pišlar A; Božić B; Zidar N; Kos J
    Neuropharmacology; 2017 Mar; 114():88-100. PubMed ID: 27889490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Directly visualized glioblastoma-derived extracellular vesicles transfer RNA to microglia/macrophages in the brain.
    van der Vos KE; Abels ER; Zhang X; Lai C; Carrizosa E; Oakley D; Prabhakar S; Mardini O; Crommentuijn MH; Skog J; Krichevsky AM; Stemmer-Rachamimov A; Mempel TR; El Khoury J; Hickman SE; Breakefield XO
    Neuro Oncol; 2016 Jan; 18(1):58-69. PubMed ID: 26433199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells.
    Cai L; Kirchleitner SV; Zhao D; Li M; Tonn JC; Glass R; Kälin RE
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Context-Dependent Glioblastoma-Macrophage/Microglia Symbiosis and Associated Mechanisms.
    Xuan W; Lesniak MS; James CD; Heimberger AB; Chen P
    Trends Immunol; 2021 Apr; 42(4):280-292. PubMed ID: 33663953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hybrids by tumor-associated macrophages × glioblastoma cells entail nuclear reprogramming and glioblastoma invasion.
    Cao MF; Chen L; Dang WQ; Zhang XC; Zhang X; Shi Y; Yao XH; Li Q; Zhu J; Lin Y; Liu S; Chen Q; Cui YH; Zhang X; Bian XW
    Cancer Lett; 2019 Feb; 442():445-452. PubMed ID: 30472185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.
    Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X
    J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Revealing and Harnessing Tumour-Associated Microglia/Macrophage Heterogeneity in Glioblastoma.
    Pires-Afonso Y; Niclou SP; Michelucci A
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973030
    [No Abstract]   [Full Text] [Related]  

  • 28. MCP-1 and MIP-3α Secreted from Necrotic Cell-Treated Glioblastoma Cells Promote Migration/Infiltration of Microglia.
    Jung Y; Ahn SH; Park H; Park SH; Choi K; Choi C; Kang JL; Choi YH
    Cell Physiol Biochem; 2018; 48(3):1332-1346. PubMed ID: 30048972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells.
    Mukherjee S; Fried A; Hussaini R; White R; Baidoo J; Yalamanchi S; Banerjee P
    J Exp Clin Cancer Res; 2018 Jul; 37(1):168. PubMed ID: 30041669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel concept of the border niche: glioblastoma cells use oligodendrocytes progenitor cells (GAOs) and microglia to acquire stem cell-like features.
    Hide T; Shibahara I; Kumabe T
    Brain Tumor Pathol; 2019 Apr; 36(2):63-73. PubMed ID: 30968276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival.
    Poli A; Wang J; Domingues O; Planagumà J; Yan T; Rygh CB; Skaftnesmo KO; Thorsen F; McCormack E; Hentges F; Pedersen PH; Zimmer J; Enger PØ; Chekenya M
    Oncotarget; 2013 Sep; 4(9):1527-46. PubMed ID: 24127551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progression.
    Yeini E; Ofek P; Pozzi S; Albeck N; Ben-Shushan D; Tiram G; Golan S; Kleiner R; Sheinin R; Israeli Dangoor S; Reich-Zeliger S; Grossman R; Ram Z; Brem H; Hyde TM; Magod P; Friedmann-Morvinski D; Madi A; Satchi-Fainaro R
    Nat Commun; 2021 Mar; 12(1):1912. PubMed ID: 33771989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Down-regulation of IKKβ expression in glioma-infiltrating microglia/macrophages is associated with defective inflammatory/immune gene responses in glioblastoma.
    Mieczkowski J; Kocyk M; Nauman P; Gabrusiewicz K; Sielska M; Przanowski P; Maleszewska M; Rajan WD; Pszczolkowska D; Tykocki T; Grajkowska W; Kotulska K; Roszkowski M; Kostkiewicz B; Kaminska B
    Oncotarget; 2015 Oct; 6(32):33077-90. PubMed ID: 26427514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oligodendrocyte Progenitor Cells and Macrophages/Microglia Produce Glioma Stem Cell Niches at the Tumor Border.
    Hide T; Komohara Y; Miyasato Y; Nakamura H; Makino K; Takeya M; Kuratsu JI; Mukasa A; Yano S
    EBioMedicine; 2018 Apr; 30():94-104. PubMed ID: 29559295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased Antiangiogenic Effect by Blocking CCL2-dependent Macrophages in a Rodent Glioblastoma Model: Correlation Study with Dynamic Susceptibility Contrast Perfusion MRI.
    Cho HR; Kumari N; Thi Vu H; Kim H; Park CK; Choi SH
    Sci Rep; 2019 Jul; 9(1):11085. PubMed ID: 31366997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microglia and glioblastoma heterocellular interplay sustains tumour growth and proliferation as an off-target effect of radiotherapy.
    Alberghina C; Torrisi F; D'Aprile S; Longhitano L; Giallongo S; Scandura G; Mannino G; Mele S; Sabini MG; Cammarata FP; Russo G; Abdelhameed AS; Zappalà A; Lo Furno D; Giuffrida R; Li Volti G; Tibullo D; Vicario N; Parenti R
    Cell Prolif; 2024 Jun; 57(6):e13606. PubMed ID: 38454614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug-resistance mechanisms of recurrent glioblastoma.
    Wu H; Guo C; Wang C; Xu J; Zheng S; Duan J; Li Y; Bai H; Xu Q; Ning F; Wang F; Yang Q
    Cancer Sci; 2023 Jun; 114(6):2609-2621. PubMed ID: 36853018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
    Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
    Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploiting Microglial Functions for the Treatment of Glioblastoma.
    Dello Russo C; Lisi L; Tentori L; Navarra P; Graziani G; Combs CK
    Curr Cancer Drug Targets; 2017; 17(3):267-281. PubMed ID: 27528361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.